免疫学
免疫系统
肺孢子虫肺炎
生物
获得性免疫系统
T细胞
流式细胞术
先天免疫系统
PD-L1
免疫
巨噬细胞极化
巨噬细胞
免疫疗法
耶氏肺孢子虫
体外
人类免疫缺陷病毒(HIV)
生物化学
作者
Chao Zhang,Heng-Mo Rong,Ting Li,Kan Zhai,Zhao-Hui Tong
标识
DOI:10.1165/rcmb.2019-0234oc
摘要
Abstract Pneumocystis is an unusual, opportunistic fungal pathogen capable of causing Pneumocystis pneumonia (PCP) in immunocompromised hosts. Although PCP was discovered >100 years ago, its pathogenesis remains unclear. The inhibitory receptor PD-1 (programmed death 1), a negative regulator of activated T cells, has been reported to take part in tumor escape, immune tolerance, and infection immunity. In this study, we examined the role of the PD-1/PD-L1 (programmed death-ligand 1) pathway in patients with PCP and in mice. The expression levels of PD-1/PD-L1 in patients with PCP and in mice were measured by real-time PCR and flow cytometry. The effects of PD-1 deficiency are demonstrated using wild-type and PD-1−/− mice. Our data show that Pneumocystis infection promotes PD-1/PD-L1 expression; PD-1 deficiency enhances the phagocytic function of macrophages and the pulmonary T-helper cell type 1 (Th1)/Th17 response, which might contribute to Pneumocystis clearance; and PD-1 deficiency affects the polarization of macrophages. PCP mice treated with anti–PD-1 antibody showed improved pulmonary clearance of Pneumocystis. Collectively, our results demonstrate that the PD-1/PD-L1 pathway plays a role in regulating the innate and adaptive immune responses, suggesting that manipulation of this pathway may constitute an immunotherapeutic strategy for PCP.
科研通智能强力驱动
Strongly Powered by AbleSci AI